ID: ALA2336372

Max Phase: Preclinical

Molecular Formula: C9H13N9

Molecular Weight: 247.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)c1nc(N)nc2c1ncn2CCN=[N+]=[N-]

Standard InChI:  InChI=1S/C9H13N9/c1-17(2)7-6-8(15-9(10)14-7)18(5-12-6)4-3-13-16-11/h5H,3-4H2,1-2H3,(H2,10,14,15)

Standard InChI Key:  BTIZUQOCTJSNPA-UHFFFAOYSA-N

Associated Targets(Human)

Aurora kinase A/B 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 247.27Molecular Weight (Monoisotopic): 247.1294AlogP: 0.78#Rotatable Bonds: 4
Polar Surface Area: 121.62Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.37CX LogP: 0.61CX LogD: 0.49
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.49Np Likeness Score: -0.76

References

1. Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V..  (2013)  Synthesis and biological evaluation of guanidino analogues of roscovitine.,  62  [PMID:23399722] [10.1016/j.ejmech.2013.01.021]

Source